Kambiz Yazdi
Stock Analyst at BTIG
(4.59)
# 916
Out of 4,520 analysts
66
Total ratings
69.2%
Success rate
29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Rated: Buy | $49 → $57 | $32.88 | +73.36% | 7 | Jul 16, 2026 | |
| KZIA Kazia Therapeutics | Maintained: Buy | $34 | $13.34 | +154.87% | 2 | Jul 15, 2026 | |
| RAPP Rapport Therapeutics | Maintained: Buy | $65 | $42.62 | +52.51% | 8 | Jul 15, 2026 | |
| ZVRA Zevra Therapeutics | Rated: Buy | $27 | $12.77 | +111.43% | 4 | Jul 1, 2026 | |
| ABSI Absci | Maintained: Buy | $13 | $8.30 | +56.72% | 3 | Jul 1, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $810 | $314.41 | +157.63% | 15 | Jun 29, 2026 | |
| SION Sionna Therapeutics | Rated: Buy | $58 | $49.41 | +17.39% | 7 | May 12, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €75.60 | +60.05% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $31 | $28.49 | +8.81% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $79.94 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $19.37 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $13.30 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.34 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $14 | $0.368 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0052 | n/a | 1 | May 31, 2023 |
vTv Therapeutics
Jul 16, 2026
Rated: Buy
Price Target: $49 → $57
Current: $32.88
Upside: +73.36%
Kazia Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: $34
Current: $13.34
Upside: +154.87%
Rapport Therapeutics
Jul 15, 2026
Maintained: Buy
Price Target: $65
Current: $42.62
Upside: +52.51%
Zevra Therapeutics
Jul 1, 2026
Rated: Buy
Price Target: $27
Current: $12.77
Upside: +111.43%
Absci
Jul 1, 2026
Maintained: Buy
Price Target: $13
Current: $8.30
Upside: +56.72%
Praxis Precision Medicines
Jun 29, 2026
Maintained: Buy
Price Target: $810
Current: $314.41
Upside: +157.63%
Sionna Therapeutics
May 12, 2026
Rated: Buy
Price Target: $58
Current: $49.41
Upside: +17.39%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €75.60
Upside: +60.05%
Arcutis Biotherapeutics
Jan 15, 2026
Maintained: Buy
Price Target: $31
Current: $28.49
Upside: +8.81%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $79.94
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $19.37
Upside: n/a
Aug 28, 2024
Maintained: Buy
Price Target: $15
Current: $13.30
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.34
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $15 → $14
Current: $0.368
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0052
Upside: n/a